staurosporine has been researched along with ku 55933 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
Bonner, WM; D'Ambrosio, E; Kumari, D; Nakamura, AJ; Somma, V; Usdin, K | 1 |
Chwastek, J; Jantas, D; Lasoń, W | 1 |
3 other study(ies) available for staurosporine and ku 55933
Article | Year |
---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome.
Topics: Aphidicolin; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Chromosome Breakage; Chromosome Fragile Sites; Chromosome Fragility; DNA Damage; DNA Repair; DNA-Binding Proteins; Floxuridine; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Knockdown Techniques; Histones; Humans; Male; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrones; Staurosporine; Tumor Suppressor Proteins | 2009 |
The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Calpain; Caspase 3; Cathepsin D; Cell Death; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Histones; Humans; Hydrogen Peroxide; Mice; Morpholines; Neurons; Neuroprotective Agents; Phosphoproteins; Protein Kinase Inhibitors; Pyrones; Rats; Staurosporine; Tumor Suppressor Protein p53 | 2017 |